Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies

Alain P. Algazi^*, Katy K. Tsai, Alexander N. Shoushtari, Rodrigo R. Munhoz, Zeynep Eroglu, Josep M. Piulats, Patrick A. Ott, Douglas B. Johnson, Jimmy Hwang, Adil I. Daud, Jeffrey A. Sosman, Richard D. Carvajal, Bartosz Chmielowski, Michael A. Postow, Jeffrey S. Weber, Ryan J. Sullivan

^*Corresponding author for this work